Bioactive Compounds
-
A3753 Reparixin L-lysine salt1 CitationTarget: CXCRSummary: CXCR1/CXCR2 inhibitor -
A3758 Retigabine dihydrochlorideSummary: Antiepileptic compound -
A3763 RG73882 CitationSummary: MDM2 antagonist, oral, selective -
A3768 RivastigmineSummary: Cholinesterase inhibitor -
A3779 RS 5043931 CitationSummary: CCR2 chemokine receptor antagonist -
A3817 SildenafilTarget: Phosphodiesterases (PDEs)Summary: PDE5 inhibitor, selective -
A3858 TaranabantSummary: Cannabinoid receptor type 1 inverse agonist -
A3860 TasquinimodSummary: Antiangiogenic and antineoplastic agent -
A3877 Tirofiban hydrochloride monohydrateSummary: Glycoprotein IIb/IIIa inhibitor -
A3885 TozadenantTarget: Adenosine A2A ReceptorsSummary: Adenosine 2a receptor antagonist,novel and selective

